BDNF data

University researchers presented the results of phase I/II trials of BDNF for ALS at the American Neurologic Association meeting in Washington, D.C.

A total of 283 patients participated in the trials at 21 centers in the U.S. and Canada, including 59 randomized to placebo. Doses of drug were 10, 25, 50, 100, 150, and 300 mg/kg/day. ...